Papillomavirus Vaccines

"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.

Descriptor ID	D053918
MeSH Number(s)	D20.215.894.899.498
Concept/Terms	Papillomavirus Vaccines Papillomavirus Vaccines Vaccines, Papillomavirus Human Papillomavirus Vaccines Human Papillomavirus Vaccines Papillomavirus Vaccines, Human Vaccines, Human Papillomavirus Human Papilloma Virus Vaccines HPV Vaccines

Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Viral Vaccines [D20.215.894.899]
Papillomavirus Vaccines [D20.215.894.899.498]

Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".

Papillomavirus Vaccines
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.

Bar chart showing 57 publications over 19 distinct years, with a maximum of 8 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	4	0	4
2008	1	0	1
2009	1	1	2
2010	2	1	3
2011	1	0	1
2012	2	0	2
2013	1	0	1
2014	3	1	4
2015	3	0	3
2016	2	1	3
2017	2	1	3
2018	2	0	2
2019	8	0	8
2020	5	0	5
2021	3	0	3
2022	6	0	6
2023	4	0	4
2024	1	0	1
2025	1	0	1

Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.

Evett S, Walker S, Ryan GW, Steere E, Daly E, Janio EA, Pedraza Marin S, Askelson NM. Evaluating implementation by rural clinics of evidence-based interventions to promote HPV vaccination. J Rural Health. 2025 Jan; 41(1):e70006.

View in: PubMed
Wong TY, Adzibolosu NK, Mattei LH, Speak AC, Morris RT, Polan RM. Disparities in contemporary human papilloma virus vaccination uptake among adult women living in the United States: An All of Us Research Program study. Gynecol Oncol. 2024 Dec; 191:100-105.

View in: PubMed
Ryan GW, Miotto MB, McReynolds C, Lemon SC, Pbert L, Trivedi M. Pediatricians' perspectives on COVID-19 and HPV vaccine hesitancy. Hum Vaccin Immunother. 2023 08 01; 19(2):2225388.

View in: PubMed
Escoffery C, Petagna C, Agnone C, Perez S, Saber LB, Ryan G, Dhir M, Sekar S, Yeager KA, Biddell CB, Madhivanan P, Lee S, English AS, Savas L, Daly E, Vu T, Fernandez ME. A systematic review of interventions to promote HPV vaccination globally. BMC Public Health. 2023 06 29; 23(1):1262.

View in: PubMed
Askelson N, Ryan G, McKernan S, Scherer A, Daly E, Avdic L. Engaging new partners in human papillomavirus (HPV) vaccine promotion: Considerations for training private practice dental professionals in HPV vaccine promotion. J Public Health Dent. 2023 06; 83(2):185-192.

View in: PubMed
Ryan GW, Charlton ME, Scherer AM, Ashida S, Gilbert PA, Daly E, Askelson NM. Understanding Implementation of Evidence-Based Interventions to Address Human Papillomavirus Vaccination: Qualitative Perspectives of Middle Managers. Clin Pediatr (Phila). 2023 10; 62(10):1193-1200.

View in: PubMed
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews JI, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE. Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant. JCI Insight. 2022 10 10; 7(19).

View in: PubMed
Cox JE, Bogart LM, Elliott MN, Starmer AJ, Meleedy-Rey P, Goggin K, Banerjee T, Samuels RC, Hahn PD, Epee-Bounya A, Allende-Richter S, Fu CM, Schuster MA. Improving HPV Vaccination Rates in a Racially and Ethnically Diverse Pediatric Population. Pediatrics. 2022 10 01; 150(4).

View in: PubMed
Ryan G, Ashida S, Gilbert PA, Scherer A, Charlton ME, Kahl A, Askelson N. The Use of Medical Claims Data for Identifying Missed Opportunities for HPV Immunization Among Privately Insured Adolescents in the State of Iowa. J Community Health. 2022 10; 47(5):783-789.

View in: PubMed
Casta?eda-Avila MA, Oramas Sep?lveda CJ, P?rez CM, Ramos-Cartagena JM, Acosta Pag?n K, P?rez-Santiago J, Godoy-Vitorino F, Ortiz AP. Sex and educational attainment differences in HPV knowledge and vaccination awareness among unvaccinated-sexually active adults in Puerto Rico. Hum Vaccin Immunother. 2022 11 30; 18(5):2077065.

View in: PubMed

People

Explore

Similar Concepts

Top Journals